A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease.
Frankel, J P
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease. [electronic resource] - Clinical neuropharmacology Oct 1989 - 448-51 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0362-5664
10.1097/00002826-198910000-00010 doi
Adjuvants, Pharmaceutic
Aged
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Levodopa--therapeutic use
Middle Aged
Parkinson Disease--drug therapy
Phenethylamines--administration & dosage
Selegiline--administration & dosage
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease. [electronic resource] - Clinical neuropharmacology Oct 1989 - 448-51 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0362-5664
10.1097/00002826-198910000-00010 doi
Adjuvants, Pharmaceutic
Aged
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Levodopa--therapeutic use
Middle Aged
Parkinson Disease--drug therapy
Phenethylamines--administration & dosage
Selegiline--administration & dosage